Aclaris therapeutics to participate in three november healthcare conferences

Wayne, pa., oct. 29, 2025 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the company will participate in three upcoming healthcare conferences in november. on wednesday november 12, 2025, at 11:00 am est, aclaris' chief executive officer dr. neal walker and other members of aclaris' senior leadership team will participate in a fireside chat during the guggenheim 2nd annual healthcare conference in boston, ma.
ACRS Ratings Summary
ACRS Quant Ranking